Giles Dudley

Giles Dudley is an experienced professional in the life sciences sector, currently serving as Chief Business Officer at Stimuliver and AdaptVac, focusing on cell therapy and vaccine development, respectively. Additionally, Giles contributes as a Spark Program Member and Advisor, supporting the advancement of research from universities to industry. With a robust background in business development at the BioInnovation Institute and advisory roles for various startups, including Twelve Bio and 2N Pharma, Giles has demonstrated expertise in therapeutic areas such as CNS disorders and male infertility. Academic qualifications include a PhD in Virology from the University of Glasgow and a B.Sc. in Molecular Biology and Biochemistry from the University of the West of England.